Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 63

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 63
---
 months ended December 31, 2023, as compared to $34.6 million for the twelve months ended December 31, 2022. Research and development

|                          |     | Twelve         
 Months Ended   
 December 31,   
 (In thousands) | 2023 |     |   |  2022 |     | Changes | Amount |   |     |     | %   |    |
|:-------------------------|:----|:---------------|-----:|:----|:--|------:|:----|:--------|:-------|:--|:----|:----|:----|:---|
| Research and development |     | $              |  799 |     | $ | 8,138 |     | $       | (7,339 | ) |     |     | (90 | )% |

Research and development expenses decreased by $7.3 million, or 90% to $0.8 million for the twelve months ended December 31, 2023, as compared to $8.1. million for the twelve months ended December 31, 2022. Sales and marketing

|                     |     | Twelve Months Ended 
 December            
 31,                 
 (In thousands)      |  2023 |     |   |  2022 |     | Changes | Amount |   |     |     | %   |    |
|:--------------------|:----|:--------------------|------:|:----|:--|------:|:----|:--------|:-------|:--|:----|:----|:----|:---|
| Sales and marketing |     | $                   | 4,670 |     | $ | 6,650 |     | $       | (1,980 | ) |     |     | (30 | )% |

Sales and marketing expenses decreased by $1.98 million, or 30% to $4.7 million for the twelve months ended December 31, 2023, as compared to $6.7 million for the twelve months ended December 31, 2022. General and administrative

|                            |     | Twelve         
 Months Ended   
 December 31,   
 (In thousands) |  2023 |     |   |  2022 |     | Changes | Amount |     |     | % |   |
|:---------------------------|:----|:---------------|------:|:----|:--|------: